VentriPoint Diagnostics Ltd V.VPT

This is what VPT CEO Hugh will be presenting on June 25th🚀

[jopatclo]

Interesting comment This is what Ventripoint's CEO Hugh MacNaught will be presenting on June 25th at The Data Effect in Vancouver,

Miro CernetigMiro Cernetig • 3rd+ • 3rd+CEO and Owner of CityAge.com Join CityAge’s global network of over 25,000 visionaries to connect with technologies and people building the future. Free membership belowCEO and Owner of CityAge.com Join CityAge’s global network of over 25,000 visionaries to connect with technologies and people building the future. Free membership below

Subscribe to newsletter

5d • 5 days ago

Follow

 

A.I. is really impacting our health care system.
The idea of being able to give almost any patient access to a heart scan in the fraction of the time and cost of an MRI, using what amounts to ultrasounds that use A.I. to create high-fidelity images, is a remarkable advancement.

This is what Ventripoint's CEO Hugh MacNaught will be presenting on June 25th at The Data Effect in Vancouver, to some of Canada's top health care leaders.

It's a made-in-Canada health-tech breakthrough, that leading hospitals are using.
 

Hugh MacNaughtHugh MacNaught • Following • FollowingPresident and CEO at Ventripoint Diagnostics Ltd.President and CEO at Ventripoint Diagnostics Ltd.5d • 5 days ago

During the past several months Ventripoint has released VMS+ V3.2 and submitted V4.0 to FDA for 510(k) clearance. We are now preparing for product launch and market entry for what we believe is a product that promises true benefits for patients, clinicians and healthcare providers.

Developing great products is no longer enough to succeed. The “build it, and they will come” mindset will no longer lead to success in an increasingly competitive and “noisy” environment. As medical products become more sophisticated and customers are facing more demands on their time, focus and budgets, the path to market awareness and adoption has become much more complicated.

To better position Ventripoint to navigate this new reality we are evolving the company towards a market-driven culture in which the product management discipline will function to align our development team and products with customer need. We are building the insights and capability to better articulate the benefits and value of VMS+ to key segments and indications, and will focus future development activities on strengthening the user experience.

This takes a multi-disciplinary approach that combines deep technical, clinical and market knowledge.   We believe this higher level of expertise will drive our commercial success and become a source of competitive advantage. We are continuing to recruit team members with the experience and unique skills to create impact, and look forward to sharing our successes as VMS+ is integrated into clinical practice.